LOS ANGELES--(BUSINESS WIRE)--
Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Medtronic plc (“Medtronic” or the “Company”) (NYSE: MDT) investors concerning the Company and its officers’ possible violations of federal securities laws. To obtain information or aid in the investigation, please visit the Medtronic investigation page on our website at www.glancylaw.com/case/medtronic-plc.
On July 17, 2017, the Company disclosed that a June 2017 computer crash that shut down Medtronic’s global ordering, fulfillment, and manufacturing systems would crimp the Company’s quarterly sales.
On this news, the Company’s share price fell 2.8% on July 17, 2017, thereby injuring investors.
If you purchased Medtronic securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170718006045/en/
